Editas Medicine (EDIT) Total Liabilities (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Total Liabilities data on file, last reported at $159.2 million in Q4 2025.

• Total Liabilities for Q4 2025 came in at $159.2 million, down 23.19% year-over-year; the trailing twelve-month figure through Dec 2025 was $159.2 million (down 23.19% YoY), and the FY2025 annual result was $159.2 million, down 23.19% from the prior year.
• Total Liabilities eased to $159.2 million in Q4 2025 per EDIT's latest filing, from $188.3 million in the prior quarter.
• Over five years, Total Liabilities peaked at $207.3 million in Q4 2024 and troughed at $110.3 million in Q1 2022.
• A 5-year average of $150.8 million and a median of $146.3 million in 2023 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2021 and 2024: Total Liabilities tumbled 38.71% in 2021, then jumped 38.16% in 2024.
• A 5-year view of Total Liabilities shows it stood at $123.8 million in 2021, then rose by 24.06% to $153.6 million in 2022, then retreated by 2.33% to $150.1 million in 2023, then jumped by 38.16% to $207.3 million in 2024, then decreased by 23.19% to $159.2 million in 2025.
• Business Quant data shows EDIT's Total Liabilities at $159.2 million in Q4 2025, $188.3 million in Q3 2025, and $191.4 million in Q2 2025.